Stock Analyst Initiations Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsALLOAllogene Therapeutics Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.47-2.0% $7.00BuyALNYAlnylam Pharmaceuticals Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$170.04-4.1% $171.00Equal WeightAVTEAerovate Therapeutics Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$17.04+2.3% $35.00Equal WeightBBIOBridgeBio Pharma Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$32.52-3.2% $58.00OverweightBCALSouthern California Bancorp Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$15.51-0.6%Equal WeightBHVNBiohaven Initiated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.06+0.2% $58.00Outperform Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BRBRBellRing Brands Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$53.44-1.5% $60.00NeutralBWMNBowman Consulting Group Initiated byRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.22+1.7% $45.00BuyCBFVCB Financial Services Initiated byJanney Montgomery ScottSubscribe to MarketBeat All Access for the recommendation accuracy rating$23.04-0.5% $25.00NeutralCELCCelcuity Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.78-0.3% $27.00BuyCLHClean Harbors Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$171.31+1.0% $190.00OverweightCOGTCogent Biosciences Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$8.64-1.5% $18.00OverweightCVBFCVB Financial Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.62+1.0% $21.00Equal WeightDAVAEndava Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$69.54+2.3% $77.00NeutralEBEventbrite Initiated byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$7.80+5.7% $13.00BuyETSYEtsy Initiated byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$80.08+1.4% $100.00BuyEWBCEast West Bancorp Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$68.62+1.9% $79.00OverweightFRPTFreshpet Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$76.25+1.0% $104.00BuyGLPIGaming and Leisure Properties Initiated byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$46.08-0.6% $51.00NeutralHSYHershey Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$185.74-1.8% $205.00NeutralHUBBHubbell Initiated byTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy rating$308.17+0.6% $338.00OutperformINSMInsmed Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$27.96+1.4% $55.00OverweightKROSKeros Therapeutics Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$35.65+0.4% $60.00OverweightKVYOKlaviyo Initiated byLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$29.88+4.0% $40.00BuyLANCLancaster Colony Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$166.42-1.4% $185.00NeutralMDLZMondelez International Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$71.09-0.7% $83.00BuyMLTXMoonLake Immunotherapeutics Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$55.40+0.3% $72.00BuyMORFMorphic Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$27.17+2.2% $46.00BuyNBTXNanobiotix Initiated bySVB LeerinkSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.74-3.7% $11.00OutperformNEENextEra Energy Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$59.70-0.3% $69.00BuyNVNINvni Group Initiated byMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.60+8.8% $5.00BuyNXSTNexstar Media Group Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$148.63+4.4% $158.00NeutralPLRXPliant Therapeutics Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$14.63-0.5% $41.00OverweightPRMEPrime Medicine Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.50-0.7% $10.00NeutralPTCTPTC Therapeutics Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$26.39+0.4% $37.00OverweightQSIQuantum-Si Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.57+1.3% $3.00BuyRAREUltragenyx Pharmaceutical Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$40.46-2.3% $72.00OverweightRDFNRedfin Initiated byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$8.11+2.4% $8.00NeutralSLABSilicon Laboratories Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$121.89+3.6% $145.00OverweightSLDBSolid Biosciences Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.06-12.2% $9.00BuySLRNAcelyrin Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$6.83-4.6% $8.00NeutralSMPLSimply Good Foods Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$39.79-1.4% $42.00NeutralSOSouthern Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$71.50-0.2% $82.00BuySRCLStericycle Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$48.45-1.3% $40.00UnderweightSTKLSunOpta Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.86+1.5% $8.00BuySYNASynaptics Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$106.75+7.2% $130.00OverweightTNGXTango Therapeutics Initiated byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$9.18+7.4% $16.00BuyUTHRUnited Therapeutics Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$241.65-0.2% $309.00OverweightVICIVICI Properties Initiated byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$30.51+0.3% $36.00BuyVITLVital Farms Initiated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$15.21+3.8% $21.00BuyVTLEVital Energy Initiated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$42.57+0.4% $48.00UnderperformWAFDWaFd Initiated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$30.56+0.9% $32.00Equal WeightXENEXenon Pharmaceuticals Initiated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating$38.34-1.8% $63.00OutperformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:08 AM ET. Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage. Email Address Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.